News

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...
From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapiesComplements and further expands ReciBioPharm’s AAV offeringAchieves industry-leading ...
By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...
CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...
Sarepta has submitted a request to the FDA to include the death case in Elevidys’ label, and the agency plans to review the ...
Astraveus inks partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory for CAR-T therapy manufacturing: Paris, France Wednesday, May 7, 2025, 15:00 Hrs [IST] Astraveu ...
A gene therapy has restored immune function in nine children with severe leukocyte adhesion deficiency-I, a rare immune disorder ...
As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are hurdles to overcome.
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced important derisking events in the pathway to a planned BLA submission for isaralgagene civaparvovec, or ST-920, its wholly ...
Cell and gene therapies (CGTs) are revolutionizing the landscape of personalized medicine, offering treatments that were once ...
A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.